MedTrace Logo

A Study to Learn What Participants Think of Treatment With Betamethasone Plus Loratadine to Treat Their Acute Allergic Rhinitis, Also Known as Hay Fever in Mexico

NCT04645979 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 153

Last updated 2023-06-01

No results posted yet for this study

Summary

Acute allergic rhinitis is a common allergic reaction to things like pollen or dust. It causes inflammation inside the nose, resulting in symptoms similar to the common cold. Allergic rhinitis is also known as hay fever.

In this study, the researchers want to learn what participants think of betamethasone plus loratadine as a treatment for their acute allergic rhinitis. These participants will have used betamethasone plus loratadine as a treatment for their acute allergic rhinitis within the past two months. During the study, participants will complete an online questionnaire about their experience with betamethasone plus loratadine.

Conditions

  • Rhinitis, Allergic

Interventions

OTHER

Online survey

Participants will be invited to complete an online questionnaire about their experience of product use.

Sponsors & Collaborators

Eligibility

Min Age
20 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-11
Primary Completion
2020-11-27
Completion
2020-11-27

Countries

  • Mexico

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04645979 on ClinicalTrials.gov